ORCHPHARMA.NSORCHPHARMA.NSNSE
Loading
Operating Expenses Over TimeStable
Percentile Rank27
3Y CAGR+70.7%
5Y CAGR-4.7%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+70.7%/yr
vs -42.0%/yr prior
5Y CAGR
-4.7%/yr
Recent acceleration
Acceleration
+112.7pp
Accelerating
Percentile
P27
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
3 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| TTM | $2.04B | +68.9% |
| 2025 | $1.21B | +106.9% |
| 2024 | $584.47M | +42.5% |
| 2023 | $410.20M | -84.6% |
| 2022 | $2.66B | +2.3% |
| 2021 | $2.60B | -21.3% |
| 2020 | $3.30B | -9.0% |
| 2019 | $3.62B | -9.2% |
| 2018 | $3.99B | -18.2% |
| 2017 | $4.88B | - |